subscribe
 

New study discovers copper destroys highly infectious norovirus

Worldwide, norovirus is responsible for more than 267 million cases of acute gastroenteritis every year. Scientists have now discovered that...

Novartis receives EU approval for Ilaris®

Novartis receives EU approval for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis

Neutron studies of HIV inhibitors

Neutron studies of HIV inhibitors reveal new areas for improvement in drug design to enhance performance, combat resistance and reduce...

Teaching old drugs new tricks

Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new...

ELRIG Drug Discovery 2013

Students, graduates and post-docs are welcome to compete for the SLAS Young Scientist Award at the ELRIG Drug Discovery 2013 Annual...

Dolomite expertise brings microfluidic product to market

Fledgling spin-out company Drop-Tech has turned to microfluidics specialist Dolomite for its product development and fabrication skills to...

SAW Instruments enhances protein interaction analysis with the sam®X acoustic biosensor

SAW Instruments, developer of the innovative sam® family of biosensors for real-time, label-free biomolecular interaction assays, is...

Training course in preparing stable lyophilized protein formulations

SP Scientific has announced a new hands-on training course entitled 'Rapid and Rational Development of Stable Lyophilized Protein...

World leading scientists join forces to fight devastating degenerative disease

More than 200 international scientists and clinicians who are fighting to find a cure for the devastating degenerative condition Motor...

A fresh approach to developing chronic pain therapeutics

Cellectricon will present a novel phenotypic assay at World Pharma Congress 2013, Tues 4th June, 5pm

Copper destroys norovirus

New research from the University of Southampton shows that copper and copper alloys will rapidly destroy norovirus - the highly-infectious...

Scientists develop worm EEG to test the effects of drugs

Scientists from the University of Southampton have developed a device which records the brain activity of worms to help test the effects of...

Novozymes Biopharma’s recombinant human albumin helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, has announced that an ophthalmic solution made using its...

Drug-resistant tumours

A Personal DeltaVision cell microscopy imaging system supplied by Image Solutions UK Ltd. is assisting scientists at Cancer Research UK to...

Roche to present important new data reflecting broad cancer pipeline at ASCO

Roche has announced that important new data from clinical trials of several investigational and approved cancer medicines will be presented...

Lonza launches 2013-2014 BioResearch Catalog

Diabetes prevention has become a key focus area for the drug development market.

Study identifies “chink in the armour” of Schmallenberg virus

A key building block in the Schmallenberg virus could be targeted by anti-viral drugs, according to a new study led from the University of...

Genomics to reshape endometrial cancer treatment

The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the...

Drug discovery techniques focus on speed and cost reduction

Drug discovery relies on a huge range of techniques, from polymerase chain reaction analysis to clinical trial design. Here we highlight the...

New vaccine to combat Aussie flue

Seqirus to commercialise novel cell-based quadrivalent influenza vaccine in Europe

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe